Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Aposense Ltd (APOS)

Tel Aviv
Currency in ILS
Disclaimer
155.5
0.0(0.00%)
Closed
APOS Scorecard
Fair Value
Unlock Value
Day's Range
155.0155.7
52 wk Range
0.0155.7
Bid/Ask
155.10 / 156.00
Prev. Close
155
Open
155
Day's Range
155-155.7
52 wk Range
0-0
Volume
0
Average Vol. (3m)
28,435
1-Year Change
0%
Shares Outstanding
26,859,807
Fair Value
Unlock
Dividends Payment Streak
Unlock
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More
How do you feel today about APOS?
Vote to see community's results!
or

Aposense Ltd Company Profile

Aposense Ltd., a biopharmaceutical company, engages in the development of novel drugs based on proprietary integration of structural and electrical properties of biological membranes. It develops molecular nano-motors that are small-chemical entities capable of energy mining from the intra-membrane electric field. Its Apo-Si is a platform technology for the delivery of genetic drugs, such as siRNA into cells. It is involved in the development of ATT-11T, which is a conjugate of proprietary molecular nano-motor with SN-38, the active moiety of irinotecan for the treatment of solid tumors. Aposense Ltd. has a research collaboration with Bioasis Technologies Inc. to focus on the delivery of siRNA into the brain. The company was formerly known as N.S.T. Neuro Sauriol Technologies Ltd. and changed its name to Aposense Ltd. in August 2008. Aposense Ltd. was founded in 1996 and is based in Petah Tikva, Israel.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.